Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;9(3):469-477.
doi: 10.1007/s13555-019-00319-0. Epub 2019 Aug 8.

Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis

Affiliations
Review

Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis

Jaime Piquero-Casals et al. Dermatol Ther (Heidelb). 2019 Sep.

Abstract

Facial seborrheic dermatitis (FSD) is a chronic and relapsing inflammatory skin disorder occurring in areas of the face rich in sebaceous glands. It clinically manifests as erythematous scaly macules or plaques, often associated with pruritus. Although the pathogenesis of seborrheic dermatitis is not yet fully understood, Malassezia yeast, hormones, sebum levels, and immune response are known to play important roles. Additional factors including drugs, cold temperatures, and stress may exacerbate the condition. Currently, the available treatments do not cure the disease but relieve symptoms. Various pharmacological treatments are available, including antifungal agents, keratolytics, topical low-potency steroids, and calcineurin inhibitors. All of them provide several benefits, but they also have potential side effects. Seborrheic dermatitis tends to have a chronic, recurrent course. To avoid the long-term use of drugs, topical non-pharmacological products such as cosmetics or medical devices may improve clinical outcomes. Products with antimicrobial and anti-inflammatory ingredients such as zinc, piroctone olamine, dihydroavenanthramide, biosaccharide gum-2, and stearyl glycyrrhetinate may speed FSD recovery and avoid flare-ups. Finally, the use of specific cleansers, moisturizers, and sunscreens formulated as light creams or gel/creams should be strongly recommended to all FSD patients. We provide a brief review of the most used non-pharmacological cleansers, topical gel/creams, and specific sunscreens in the management of FSD.

Keywords: Cosmeceuticals; Cosmetics; Facial; Medical device; Seborrheic dermatitis; Topical treatment.

PubMed Disclaimer

Conflict of interest statement

Dr. Jaime Piquero-Casals is consultant of ISDIN. Doris Hexsel, Juan Francisco Mir-Bonafé, and Eduardo Rozas-Muñoz have nothing to disclose.

Figures

Fig. 1
Fig. 1
Seborrheic dermatitis following the typical distribution on the face. The scheme presents the cross section of the skin structure and the specific properties of the non-pharmacological anti-FSD ingredients

Similar articles

Cited by

References

    1. Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheic dermatitis. An Bras Dermatol. 2011;86(6):1061–1071. doi: 10.1590/S0365-05962011000600002. - DOI - PubMed
    1. Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208(2):89–93. doi: 10.1159/000076478. - DOI - PubMed
    1. Naldi L. Seborrhoeic dermatitis. BMJ Clin Evid. 2010;2010:1713. - PMC - PubMed
    1. Borda L, Wikramanayake T. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2). 10.13188/2373-1044.1000019. - PMC - PubMed
    1. Bukvic ZM, Kralj M, Basta-Juzbasic A, Lakos J. Seborrhoeic dermatitis: an update. Acta Dermatovenerol Croat. 2012;20(2):98–104. - PubMed

LinkOut - more resources